Literature DB >> 32276289

Renal arteriolar hyalinosis, not intimal thickening in large arteries, is associated with cardiovascular events in people with biopsy-proven diabetic nephropathy.

K Morimoto1,2, M Matsui1,2, K Samejima1,2, T Kanki2, M Nishimoto1,2, K Tanabe1,2, M Murashima1,2, M Eriguchi1, Y Akai1,2, M Iwano2, H Shiiki2, H Yamada2, M Kanauchi2, K Dohi2, K Tsuruya1, Y Saito2.   

Abstract

AIMS: Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findings and cardiovascular events has not been well studied. We aimed to investigate whether the pathological findings in diabetic nephropathy are closely associated with cardiovascular event development.
METHODS: This retrospective cohort study analysed 377 people with type 2 diabetes and biopsy-proven diabetic nephropathy, with a median follow-up of 5.9 years (interquartile range 2.0 to 13.5). We investigated how cardiovascular events were impacted by two vascular diabetic nephropathy lesions, namely arteriolar hyalinosis and arterial intimal thickening, and by glomerular and interstitial lesions.
RESULTS: Of the 377 people with diabetic nephropathy, 331 (88%) and 295 (78%) had arteriolar hyalinosis and arterial intimal thickening, respectively. During the entire follow-up period, those with arteriolar hyalinosis had higher cardiovascular event rates in the crude Kaplan-Meier analysis than those without these lesions (P = 0.005, log-rank test). When fully adjusted for clinically relevant confounders, arteriolar hyalinosis independently predicted cardiovascular events [hazard ratio (HR) 1.99; 95% confidence interval (CI) 1.12, 3.86], but we did not find any relationship between arterial intimal thickening and cardiovascular events (HR 0.89; 95% CI 0.60, 1.37). Additionally, neither glomerular nor interstitial lesions were independently associated with cardiovascular events in the fully adjusted model.
CONCLUSIONS: Arteriolar hyalinosis, but not intimal thickening of large arteries, was strongly associated with cardiovascular events in people with diabetic nephropathy.
© 2020 Diabetes UK.

Entities:  

Year:  2020        PMID: 32276289     DOI: 10.1111/dme.14301

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  4 in total

1.  The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.

Authors:  Hideo Tsushima; Ken-Ichi Samejima; Masahiro Eriguchi; Takayuki Uemura; Hikari Tasaki; Fumihiro Fukata; Masatoshi Nishimoto; Takaaki Kosugi; Kaori Tanabe; Keisuke Okamoto; Masaru Matsui; Kazuhiko Tsuruya
Journal:  Clin Exp Nephrol       Date:  2022-04-15       Impact factor: 2.617

Review 2.  The effect of probiotics on lipid profile & anthropometric indices in diabetic nephropathy; a systematic review and meta-analysis of clinical trials.

Authors:  Amir Reza Moravejolahkami; Mohammad Ali Hojjati Kermani; Zakiyeh Balouch Zehi; Seyed Mohammad Sadegh Mirenayat; Marjan Mansourian
Journal:  J Diabetes Metab Disord       Date:  2021-02-23

3.  Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy.

Authors:  Sadanori Okada; Ken-Ichi Samejima; Masaru Matsui; Katsuhiko Morimoto; Riri Furuyama; Kaori Tanabe; Masahiro Eriguchi; Yasuhiro Akai; Yoshihiko Saito; Kazuhiko Tsuruya
Journal:  BMJ Open Diabetes Res Care       Date:  2020-11

4.  Maslinic acid activates renal AMPK/SIRT1 signaling pathway and protects against diabetic nephropathy in mice.

Authors:  Huijuan Gao; Hong Wu
Journal:  BMC Endocr Disord       Date:  2022-01-18       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.